ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy of AL-53817 Nasal Spray Solution
The purpose of this study was to determine the maximum tolerated dose of AL-53817 (Stage A) and evaluate the safety and efficacy of AL-53817 for the treatment of allergic rhinitis (Stage B).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis#877316
- Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis#1044375
- Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo#1125525
- Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis#1074724
- A Randomized Controlled Trial Comparing Posterior Nasal Nerve Ablation Procedures for Chronic Rhinitis#864101
Record · ID 866156
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive